Filing Details
- Accession Number:
- 0001209191-17-046027
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-21 20:04:29
- Reporting Period:
- 2017-07-19
- Filing Date:
- 2017-07-21
- Accepted Time:
- 2017-07-21 20:04:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1242825 | M Jeffrey Leiden | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Ceo & President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-07-19 | 110,624 | $45.11 | 400,266 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-07-19 | 73,750 | $48.74 | 474,016 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-07-19 | 184,374 | $161.00 | 289,642 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-07-21 | 700 | $157.42 | 288,942 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-07-21 | 4,837 | $158.46 | 284,105 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-07-21 | 3,500 | $159.34 | 280,605 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-07-21 | 900 | $160.42 | 279,705 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-07-21 | 17,255 | $161.43 | 262,450 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-07-21 | 5,058 | $162.08 | 257,392 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-07-19 | 110,624 | $0.00 | 110,624 | $45.11 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-07-19 | 73,750 | $0.00 | 73,750 | $48.74 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 66,376 | 2023-02-04 | No | 4 | M | Direct | |
| 44,250 | 2022-07-24 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 440 | Indirect | 401k |
Footnotes
- Transaction made pursuant to Dr. Leiden's company-approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $157.42 (range $156.81 to $157.71).
- Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $158.46 (range $157.88 to $158.86).
- Open market sales reported on this line occurred at a weighted average price of $159.34 (range $158.89 to $159.77).
- Open market sales reported on this line occurred at a weighted average price of $160.42 (range $159.90 to $160.86).
- Open market sales reported on this line occurred at a weighted average price of $161.43 (range $160.92 to $161.91).
- Open market sales reported on this line occurred at a weighted average price of $162.08 (range $161.92 to $162.45).
- Fully vested.
Billionaire Hedge Funds
